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Trends in the Treatment of Post-Infarction
Patients from 1984 to 1991
TIMI Grade 2 Flow is not Equivalent to TIMI 3:
Implications for the Use of Thrombolytic
Therapy. A Meta-Analysis of the Trials
Farzin Fath-OrdDubadi 1, Tanya Y. Huehns 2, Abdullah AI-Mohammad 2,
K.J. Beall 2. 1Medical Research Council Cyclotrone Unit, Hammersmith Hospital,
London, UK; 2 Charing Cross Hospital, London, UK
No mortality n (%) p value
TIMIO--l T1M12 TIMI3 TIMI2 vs 3
TAMI1-7' 1229 34 (10.1) 13 (61) 29(4.3) NS
Vogt"'* 907 16 ( 7.1) 8 (66) 15 (27) <0.01
GUSTO 1167 34( 8.91 25 (7.4) 19 (4.41 0.08
PDoled (%) 3601 8.9**· 6.S··· 3.7 0.001
Conventionally, infarct-related arteries (IRA}with TIMI grade 0 and 1flow have
been considered as occluded and those with TIM I grade of 2 or 3 as patent.
This view has been challenged in several recent post myocardial infarction
(MI). post thrombolysis, angiographic studies indicating different clinical out-
come in patients with TIMI grade 2 flow compared to TIMI grade 3. To deter-
mine the validity of this concept we pooled the results of 12 different studies
involving 3303 patients following MI where TIMI grade flows 90 minutes af-
ter initiation of thrombolytic therapy and mortality (up to 30 days post MI)
were recorded.
'TAMI results represent acompDsite Df results from TAMil to 7 trials and "Vogt et al a
cDmpDsite Df fDur different German trials, "'TIMI 0-1 vs TIMI 2, P ~ 0.1
Conclusion; TIM I grade 3 flow IRA at 90 minute following initiation of
thrombolytic therapy is associated with 46% (odds ratio 0.52-95% CI: 0.35-
0.78) reduction in mortality compared to TIMI grade 2 flow. Patients with
TIMI grade 2 flow IRAs have similar outcome to those with TIMI grade 0 or
1. Therefore IRAs with TIMI grade 2 flow should be considered occluded
and designated as reperfusion failure rather than success. In order to im-
prove mortality post MI. it is important that new thrombolytic strategies aim
to achieve early complete and sustained (TIMI grade 3 flow) IRA patency.
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Does Primary Angioplasty Improve the
Prognosis of Patients with Diabetes and Acute
Myocardial Infarction?
Gregg W. StDne, Cindy L. Grines, Kevin F. Browne, Jean Marco, Donald Rothbaum,
James O'Keefe, GeDffrey O. Hartzler, Paul Overlie, Brian DonDhue, Noah Chelliah,
Sylvia Puchrowicz, William W. O'Neill. EI Camino Hospital, Mountain View; CA;
William Beaumont Hospital, Royal Oak, MI
To examine the effect of different reperfusion modalities in pts with DM, the
multicenter PAMI database was analyzed, in which 395 pts within 12 hours
onset of acute MI were prospectively randomized to treatment with t-PA (n =
200) vs. primary PTCA (n = 195). DM was present in 50 (13%) pts. Compared
to pts without DM, pts with DM were older (65 vs. 59 yrs, p = 0.002), more
often female (40% vs. 25%, p = 0.03), mOre frequently had HTN (68% vs.
39%, P = 0.0001), prior CHF (8% vs. 1%, P = 0.0001). multivessel disease
(76% vs. 51 %, P = 0.01) and presented later (3.8 vs. 3.0 hours, p = 0.03).
In-hospital mortality was 10.0% in pts with DM vs. 3.B% in pts without
DM (p < 0.05). By multivariate analysis of 16 variables, however, advanced
age and treatment by PTCA rather than t-PA, but not DM correlated with
in-hospital mortality.
Mortality stratified by treatment appears in the graph. Despite the appar-
ently improved prognosis of pts with DM treated with PTCA vs. t-PA. the p
value forthe x2 test for interaction effect between DM and treatment modal-
ity was 0.86; most of the benefit of PTCA was present in the elderly popula-
tion.
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In conclusion: Pts with DM and acute MI have increased mortality, primar-
ily because of advanced age. The outcome after PTCA compared to t-PA is
improved in DM largely because of PTCA's beneficial effect in the elderly.
Coronary Flow Velocity of Infarct-Related
Arteries: Physiologic Differences Between
Complete (TIMIIII) and Incomplete (TIMI 0, I, II)
Anglographic Coronary Perfusion
Frank V. Aguirre, Thomas J. Donohue, Richard G. Bach, Eugene A. Caracciolo,
Joseph A. Moore, Thomas Wolford, Alexander Khoury, Carol Mechem, Morton
J. Kern. St. Louis University. 51. Louis, MO
Infarct artery perfusion, defined by TIMI grade angiographic flow has been
demonstrated to correlate with post-infarction clinical outcome. In an at-
tempt to define physiologic differences between complete (ie, TIMI III) and
incomplete (ie, TIMI 0, I, II) angiographic grades of flow, we evaluated the
proximal (n = 19) and distal (n = 451 coronary flow velocity (CFV) of the
infarct-related artery (IRA) in 29 acute myocardial infarct patients (23 male, 6
female) before and after direct (n = 26) or rescue (n = 3) PTCA. CFV was as-
sessed proximal and distal to the IRA lesion using a 0.014" Doppler-tipped
guidewire. The mean time from symptom onset to coronary angiography
was 84 ± 7 hrs. The IRA was the LAD (n = 18). RCA (n = 7L circumflex (n =
4).
TIMI Grade Average Peak Velocity (cm/sec)
(n) Proximal (n) Post-Stenotic
0--11 (9) 19.7 ± 9.5 (21) 125 ± 7.6'
III (101 27.4 ± , 1.3 (24) 21.1 ± 12.4
Ronald D. Gregor, Iqbal R. Bata, B. RDSS MacKenzie, Pentti M. Rautaharju,
Hermann K. WDlf. Dalhousie University. Halifax NS, Canada
The purpose of this study was to determine if established recommendations
for treatment after myocardial infarction have entered clinical practice. The
Halifax MONICA database was used for this study. It contains clinical and
treatment information on all acute myocardial infarctions (AMI) in patients,
aged 25 to 74, in a defined community. The data are obtained from chart re-
views and standardized criteria are used to establish the diagnosis of AMI.
The treatment pattern of hospital-based physicians (HP) was assessed by
the frequency of major cardiac meditations prescribed at discharge of AMI
patients. The treatment pattern of family physicians (FP) was estimated by
comparing the medication profile at discharge with that on a subsequent re-
admission. There were 2827 patients discharged with a diagnosis of AMI.
Discharge medication was not recorded on 182 charts (6.4%). For the re-
maining cases a major change in prescribing pattern occurred during the
observation period. The use of aspirin IASA) rose from 16% to 78%, ACE
inhibitors (ACEi) increased from 3% to 21 %, ,8-blockers (,8B) had decreased
from 49% to 41 % but then rose to 60%. On the other hand, Ca antagonists
(CaA) rose from 25% to 50% and then declined to 36%. In 1011 patients
with re-admission, family physicians had not altered the prescription in 77%
for ASA, 84% for ACEi, 75% for {JB, and 77% for CaA. When changes were
made, addition outweighed removal for ACEi and CaA, while the opposite
happened with ASA and ,8B. There was a marginally significant decrease in
post-discharge 6-months mortality from 7.1 % to 4.3% during the observa-
tion period (p = 0.04). We conclude that post-MI prescribing of HP follows
closely the publication of major clinical trials and precedes the publication
of professional recommendations. FP generally followed the discharge pre-
scriptions, showing similar preferences for additional medication as HP. The
change in prescribing pattern may have contributed to the decreased post-
discharge mortality
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'p < 0.008 vs prDximal and distal grade III
There were no differences in post-stenotic CFV between TIMI grade 0, I
and II. Thus, distinct differences in CFV are observed in IRAs according to pre-
viously defined clinically important angiographic perfusion grades (ie, ~II vs
III). The higher distal CFVs observed among patients with angiographic "com-
plete" compared to those with "incomplete" perfusion may partially explain
their enhanced clinical outcome.
Outcome of Different Reperfusion Strategies in
Thrombolytic "Eligible" versus "Ineligible"
Patients with Acute Myocardial Infarction
Gregg W. Stone, Cindy L. Grines, Kevin F. Browne, Jean MarcD, Donald Rothbaum,
James O'Keefe, Paul Overlie, Brian Donohue, Sylvia Puchrowlcz, William W. O'Neill.
EI Camino Hospital, Mountain View. CA; William Beaumont Hospital, Royal Oak, MI
Pts considered "not eligible" for inclusion in most early U.S. thrombolytic
trials because of advanced age, late presentation, prior CABG or shock have
avery poor prognosis; thus, some have suggested broadening the criteria for
lyric eligibility. To examine the role of different reperfusion strategies In pts
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In conclusion: Pts traditionally considered thrombolytic eligible comprise a
low risk cohort, and have a favorable prognosis whether treated with primary
PTCA or t-PA. In contrast, pts historically excluded from most early lytic trials
because of advanced age, late presentation or prior CABG are at increased
risk, and may have improved survival with primary PTCA rather than throm-
bolysis.
Exercise Training in Postinfarction Patients with
Left Ventricular Dysfunction. Preliminary
Results of the Exercise in Left Ventricular
Dysfunction (ELVD) Trial
Differential Effects of Long-term Beta-Blocker
Therapy Following Thrombolysis versus
Primary Angioplasty
Follow-up Events Propranolol Placebo p-value
In = 317) (n = 339) (Cox regression)
Overall mortality 7.6% 13.6% 00078
Sudden death 4.7% 9.7% 00094
Definite or probable MI 3.8% 7.7% 0.037
MI andlor mortality 9.2% 17.4% 0.0011
ocardial infarction (AMI) who have persistent electrocardiographic (ECG) ST
segment depression (STD) are at high risk for future cardiac events when
compared with AMI pts without STD. There are little data on the long term
effects of medical therapy on acute MI pts with STD. The objectives of this
retrospective analysis were to examine in the Beta Blocker Heart Attack Trial
(BHAT) the effects of propranolol in this high risk group. Of the 2877 first MI
BHAT pts, 656 pts had persistent ECG STD from the time of admission until
randomization (9.7 ± 3.1 days after index MI). Of these, 317 pts were ran-
domized to the propranolol and 339 pts to placebo. There were no significant
baseline differences (p < 0.05) between the two groups. The median follow
up was 24.6 months.
Cox regression analysis, adjusting for baseline variables showed the rel-
ative risk of mortality and the relative risk of sudden death were 2.13 (1.22,
3.70) and 2.56 (1.27, 5.26) respectively in the placebo, compared to the pro-
pranolol group. It appears that propranolol therapy is effective in reducing
cardiac events in pts recovering from an AMI with ECG STD.
Raffl K. Krikorian, Sylvia B. Puchrowicz, James H. O'Keefe, Jr., Cindy L. Crines,
Kevin F. Browne, Donald Rothbaum, Ronald E. Vlietstra, Gregg W. Stone, William
W. O'Neill. Mid America Heart InsMute, Kansas City, MO; Beaumont Hospital, Royal
Oak,MI
The effects of chronic beta-blocker therapy (BBT) following reperfusion ther-
apy for myocardial infarction IMI) are unclear. To address this question, we
evaluated the long-term effects of BBT on patients (pts) in the PAMI study.
A total of 395 pts were raandomized to thrombolysis (t-PA) or primary angio-
plasty (PTCA); 20 pts (5%) were lost to follow-up. Mean follow-up averaged
24 months. 42% of pts in both groups received long-term BBT. The groups
with BBT I$BBT) and without BBT (8BBT) for both PTCA and t-PA treated
arms were similar with respect to age, gender, ejection fraction, hyperten-
sion, diabetes, lipids, smoking, etc.
Pantaleo Giannuzzi, Pier L. Temporelli, Marinella Gattone, Ugo Corra,
Amerigo Giordano, Luigi Tavazzi, ELVD Study Group. Clinica del uworo Foundation,
IRCCS, Cardiology Department, Veruno, Italy
Aim of this multicenter randomized study was to investigate whether long-
term physical training would influence left ventricular remodeling and func-
tion in patients (pts) with systolic dysfunction after myocardial infarction (MI).
Forty-three consecutive pts (51 ± 8 years) with :0:40% ejection fraction (EF)
and no contraindications to exercise, in I-II NYHA Class, were studied 3-5
weeks after a first Q-wave M I and 6 months later by 2D-ECHO at rest and
upright symptom-limited bicycle ergometric test. After the initial study, pts
were randomly allocated to a 6-month exercise training program (T. n 22)
or control (C, n 21). A computerized system was used to derive echocar-
diographic variables of ventricular size, function and topography. At entry,
work capacity (WC). end-diastolic (EDV) and end-systolic (ESV) volumes, EF,
extent of wall motion abnormalities (%WMA) and regional dilatation (%RD)
were similar in the two groups. After 6 months, a significant increase in WC
was observed only in T (from 4,527 ± 1,107 to 5,529 ± 1,828 Kp-m, p < 0.01)
and not in C (from 4,371 ± 1,143 to 4,268 ± 1,199 Kp-m, NS), whereas LV
volumes and %RD increased in C IEDV: from 86 ± 24 to 95 ± 29 ml!m2, p
< 0.01; ESV: from 58 ± 21 to 66 ± 26 ml/m2 , p < 0.01; %RD: from 47 ± 18
to 57 ± 22, p < 0.01) but not in T IEDV: from 84 ± 21 to 85 ± 22 ml!m2, NS;
ESV: from 56 ± 17 to 54 ± 19 ml!m2, NS; %RD: from 43 ± 18 to 45 ± 26,
NS). Conversely, %WMA decreased and EF improved in T (%WMA: from 48
± 8 to 43 ± 10, P < 0.01; EF: from 34 ± 5 to 38 ± 8%, P < 0.01), but not in
C (%WMA: from 47 ± 9 to 48 ± 12, NS; EF: from 33 ± 5 to 32 ± 7%, NS).
Thus, from these preliminary data it appears that in postinfarction pts with
poor left ventricular function long-term exercise training may attenuate the
unfavorable remodeling response and even improve both global and regional
function over time.
11023-1121
11023-1131
Stress Echo and the Risk of Reinfarction: A
Fatal Attraction?
Thrombolytic eligible Thrombolytic ineligible
PTCA l-PA P PTCA t-PA P
In = 1271 In = 117) (n = 68) In = 831
in-hosp. D 2.4% 1.7% NS 2.9% 13.3% 0.025
in-hosp. D or R 5.5% 9.4% NS 4.4% 15.7% 0.026
in-hosp. RIE 11.8% 29.1% 0.0008 7.4% 26.6% 0.002
in-hasp. stroke 0% 1.7% NS 0% 6.0% 0.04
6 month D 3.9% 1.7% NS 2.9% 15.7% 0.009
6 month D or R 8.7% 12.8% NS 7.4% 22.9% 0.009
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traditionally considered lytic "eligible" vs. "ineligible" (age> 70, MI onset >4
hours, or prior CABG). we examined the PAMI database in which 395 pts of
any age within 12 hours onset of MI were randomized tot-PA or primary PTCA
(pts with shock were excluded). Compared to lyric eligible pts, ineligible pts
were 01der(67 vs. 56 yrs, p < 0.0001). more frequently female (38% vs. 20%,
P < 0.00011. diabetic (17% vs. 10%, P = 0.03), had prior CABG (8% vs. 0%,
P < 0.0001). presented later (4.4 vs. 2.2 hours, p < 0.0001), and were more
likely to present in CI-1F (20% vs. 11%, P = 0.01). Endpoints included death
(D), reinfarction (R). recurrent ischemic events (RIE) and stroke:
Rosa Sicari, Alessandro Pingitore, Giovanni Minardi, Nicola Gandolfo,
Giovanni Seveso, Francesco Chiarella, Leonardo Bolognese, Giacomo Chiaranda,
Nunzia Petix, Maria Grazia Sciavo, Mario Previtali, Franca Margaria, Omelia Magaia,
Federico Bianchi, Salvatore Pirelli, Luis Felipe de Moura Duarte, Maria Jose de
Sousa, Silva Severi, Mauro Raciti, Patrizia Landi, Eugenio Picano, EPIC (Echo
Persantine Italian Cooperative) study group. CNR, Institute of Clinical Physiology.
Pisa, Italy
The identification of future reinfarction seems an elusive target for physio-
logic testing, consistently with the accepted notion that it is plaque type,
rather than plaque size, that matters in provoking coronary occlusion. How-
ever, large sample populations are needed to detect phenomena with a low
event rate. In addition, one should employ noninvasive stress test results
that are tightly related to the extent and severity of CAD - in a stronger way
than exercise-ECG. Aim of this study was to assess the capability of dipyri-
damole echocardiography test (DET) to predict reinfarction in patients eval-
uated early after acute uncomplicated myocardial infarction. In an updated
analysis of the EPIC Study, we assessed the value of DET in predicting rein-
farction in 1080 pts (age = 56 ± 9, 926 men and 154 women) evaluated early
(10 ± 5 days) after uncomplicated acute myocardial infarction and followed
up for 14 ± 10 months. A positive test occurred in 475 pts (44%). During
follow-up, there were 50 reinfarctions: 45 non-fatal, and 5 fatallfollowed by
cardiac death after :0:4 days from the reinfarction). Reinfarction (either non-
fatal or fatal) occurred in 30 pts with positive and in 20 with negative DET
(6.3 vs 3.3%, p < 0.01). Nonfatal reinfarction occurred in 25 patients with
positive and in 20 with negative DET (5 vs 3%, P = 0.05). Reinfarction was
fatal in 5 out of 25 reinfarcted patients with positive and in none out of 20
reinfarcted patients with negative DET (20 vs 0%, P = 0.07). The relative risk
li.e., the relative risk of the occurrence of future cardiac events in the group
with negative DET) of reinfarction was 1.9.
In conclusion, DET positivity identifies patients evaluated early after un-
complicated myocardial infarction at higher risk of reinfarction and especially
of fatal reinfarction.
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Effects of Propranolol in Patients with Their
First Acute Myocardial Infarction and Persistent
Electrocardiographic ST Segment Depression
in the Beta Blocker Heart Attack Trial
Kalyanam Shivkumar, Lonni Schultz, Sidney Goldstein, Mihai Gheorghiade. Henry
Ford Heart and Vascular Institute, Detroit, MI; Northwestern University Medical School,
Chicago,lL
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The available data suggest that patients (pts) recovering from an acute my-
